Startups · AI

Vice President, Global Head of AI for Drug Discovery (AIDD)

Genentech · 2 Locations · On-site

← All jobs
About Genentech

Genentech discovers, develops, manufactures and commercializes treatments for patients with serious and life-threatening medical conditions. Backed by North Carolina Biotechnology Center.

About the role

The Vice President and Global Head of AI for Drug Discovery (AIDD) is responsible for leading a world-class artificial intelligence and machine learning department focused on designing therapeutics across the entire Roche/Genentech Research and Early Development (RED) portfolio. Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • Advanced degree (Ph.D. or equivalent) in Computer Science, Artificial Intelligence, Computational Chemistry, Machine Learning, Computational Biology, or a related quantitative field
  • Familiarity with drug discovery - molecule design and therapeutic discovery
  • Expertise in modern artificial intelligence, deep learning architectures, generative models, and ideally molecular modeling, and computational drug discovery
  • Demonstrated experience with advancing state-of-the-art AI infrastructure
  • Record of leading foundation model or large-scale engineering efforts, or of building research groups recognized in the external AI community
More about this role

The Vice President and Global Head of AI for Drug Discovery (AIDD) is responsible for leading a world-class artificial intelligence and machine learning department focused on designing therapeutics across the entire Roche/Genentech Research and Early Development (RED) portfolio. As a member of the Computational Sciences Center of Excellence (CSCoE) leadership team, you will also play a critical role in advancing the development and deployment of Artificial Intelligence (AI) and other computational methods across Research and Early Development at Roche the REDs.

Key responsibilities include building, scaling, and deploying cutting-edge AI methodologies, models, and computational frameworks for antibody design, protein engineering, and small molecule design. Additionally, the Global Head will partner closely with Discovery, Early Development, Therapeutic Area leads, and Translational teams to ensure the methods developed can be applied across the Roche/Genentech portfolio. The Global Head will display outstanding leadership skills—building and mentoring an elite team of AI scientists, machine learning engineers, and computational researchers into a cohesive, high-impact...

Read the full posting on Genentech's site ↗

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.